X4 Pharmaceuticals Inc.
0.48
0.02 (5.31%)
At close: Jan 15, 2025, 10:46 AM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Revenue n/a n/a n/a 3.00M n/a 3.50M n/a n/a n/a
Cost of Revenue 2.00M 1.99M 1.89M n/a 672.00K 103.00K 195.00K 300.00K 400.00K
Gross Profit -2.00M -1.99M -1.89M 3.00M -672.00K 3.40M -195.00K -300.00K -400.00K
Operating Income -107.52M -87.57M -85.11M -59.87M -51.70M -45.88M -36.13M -24.35M -14.82M
Interest Income 4.58M 219.00K 10.00K 273.00K 1.20M 809.00K 214.00K n/a n/a
Pretax Income -101.09M -93.84M -88.68M -61.98M -52.81M -43.02M -33.88M -22.98M -13.22M
Net Income -101.17M -93.87M -88.70M -62.13M -56.60M -43.02M -33.88M -22.98M -13.22M
Selling & General & Admin 35.51M 27.02M 24.70M 20.94M 17.64M 18.41M 8.01M 6.51M 2.12M
Research & Development 70.02M 61.06M 50.65M 41.93M 30.16M 30.98M 28.13M 17.83M 12.71M
Other Expenses n/a -6.27M -3.57M -2.11M -1.10M -85.00K -16.00K 104.00K -77.00K
Operating Expenses 107.52M 88.08M 75.35M 62.87M 47.80M 46.21M 32.27M 21.96M 12.67M
Interest Expense 5.78M 3.99M 3.64M 2.69M 2.15M 1.04M 2.08M 2.52M 472.00K
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 107.52M 88.08M 75.35M 62.87M 47.80M 46.21M 32.27M 21.96M 12.67M
Income Tax 78.00K 28.00K 17.00K 148.00K 3.80M 3.90M 1.87M 2.62M 395.00K
Shares Outstanding (Basic) 177.81M 63.53M 25.75M 20.08M 11.53M 459.00K 343.64K 928.01K 928.01K
Shares Outstanding (Diluted) 177.81M 63.53M 25.75M 20.08M 11.53M 459.00K 343.64K 928.01K 928.01K
EPS (Basic) -0.57 -1.48 -3.44 -3.09 -4.91 -93.73 -98.58 -24.76 -14.24
EPS (Diluted) -0.57 -1.48 -3.44 -3.09 -4.91 -93.73 -98.58 -24.76 -14.24
EBITDA -107.10M -87.57M -85.11M -58.06M -51.70M -45.88M -31.60M -20.16M -12.35M
Depreciation & Amortization 419.00K 1.99M 1.89M 1.23M 672.00K 103.00K 195.00K 300.00K 389.00K